DJIA 18,232.02 -53.72 -0.29%
NASDAQ 5,089.36 -1.43 -0.03%
S&P 500 2,126.06 -4.76 -0.22%
market minute promo

The Medicines Company (NASDAQ: MDCO)

27.09 -0.39 (-1.42%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

MDCO $27.09 -1.42%
Company Photos
(Click to zoom)
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $27.31
Previous Close $27.48
Daily Range $27.00 - $27.64
52-Week Range $19.92 - $32.44
Market Cap $1.8B
P/E Ratio -80.82
Dividend (Yield) $0.00 (0.0%)
Volume 757,588
Average Daily Volume 1,125,450
Current FY EPS $0.10

Sector

Healthcare

Industry

Drug Makers

The Medicines Company (MDCO) Description

A pharmaceutical company provides innovative, cost effective acute care hospital products to the worldwide hospital marketplace. Website: http://www.themedicinescompany.com/

News & Commentary Rss Feed

Alnylam Pharmaceuticals, Inc.'s Five-Year Plan

The biotech updated investors on its Alnylam 2020 plan during its first-quarter earnings announcement.

Alnylam's Q1 Loss Narrower than Expected, Confirms Guidance - Analyst Blog

The Medicines Co. Incurs Loss in Q1, Angiomax Sales Fall - Analyst Blog

The Medicines (MDCO) Clive A. Meanwell on Q1 2015 Results - Earnings Call Transcript

The Medicines (MDCO) Q1 2015 Results - Earnings Call Webcast

Health Care Sector Update for 05/01/2015: LPNT, MDCO

The Zacks Analyst Blog Highlights: Amgen, Medicines, Athersys and Alnylam - Press Releases

Biotech Stock Roundup: Amgen Starts Earnings Season on Strong Note, Setbacks for Ampio & Athersys -

Biotech Stock Roundup: Amgen Starts Earnings Season on Strong Note, Setbacks for Ampio & Athersys - Analyst Blog

The Medicines Co.'s New Minocin Formulation Approved - Analyst Blog

The Medicines Co.'s New Minocin Formulation Approved - Analyst Blog

Insider Trading Alert - AMP, MDCO And MEMP Traded By Insiders

See More MDCO News...

MDCO's Top Competitors

MDCO $27.09 (-1.42%)
Current stock: MDCO
JNJ $101.35 (-1.04%)
Current stock: JNJ
PFE $34.28 (-0.23%)
Current stock: PFE
RHHBY $36.83 (-0.94%)
Current stock: RHHBY